Implantable Cardioverter-Defibrillator Therapy After Acute Myocardial InfarctionThe Results Are Not Shocking
Jeffrey J. Goldberger, MD* and
Rod Passman, MD, MSCE
Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois
View larger version (19K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 1 Rates of Sudden Death or Cardiac Arrest
Rates of sudden death or cardiac arrest with resuscitation after acute myocardial infarction, stratified by left ventricular ejection fraction (LVEF). The yellow line indicates LVEF  30% (n = 3,852); the red line indicates LVEF 31% to 40% (n = 4,998); and the blue line indicates LVEF >40% (n = 2,406). Reprinted with permission from Solomon et al. (2).
|
|
View larger version (20K):
[in this window]
[in a new window]
[Download PPT slide]
|
Figure 2 Estimates for All-Cause Mortality
Kaplan-Meier estimates for all-cause mortality in the DINAMIT trial (3). ICD = implantable cardioverter-defibrillator. Reprinted with permission from Hohnloser et al. (3).
|
|
|
